A reterospective study the use of taxanes with PH and patient outcomes after receiving PHP or PHD as first-line treatment for HER2+ mBC in a real-world setting
Latest Information Update: 17 Jan 2020
At a glance
- Drugs Pertuzumab/trastuzumab (Primary) ; Docetaxel; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
Most Recent Events
- 17 Jan 2020 New trial record
- 14 Dec 2019 Results presented at the 42nd Annual San Antonio Breast Cancer Symposium